Bill Text: CA AB2871 | 2023-2024 | Regular Session | Amended


Bill Title: Overdose fatality review teams.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-04-25 - Re-referred to Com. on APPR. [AB2871 Detail]

Download: California-2023-AB2871-Amended.html

Amended  IN  Assembly  April 24, 2024

CALIFORNIA LEGISLATURE— 2023–2024 REGULAR SESSION

Assembly Bill
No. 2871


Introduced by Assembly Member Maienschein

February 15, 2024


An act to add Division 10.1 (commencing with Section 11675) to the Health and Safety Code, relating to public health.


LEGISLATIVE COUNSEL'S DIGEST


AB 2871, as amended, Maienschein. Overdose fatality review teams.
Existing law requires a county coroner to inquire into and determine the circumstances, manner, and cause of certain deaths. Existing law either requires or authorizes a county coroner, under certain circumstances, to perform, or cause to be performed, an autopsy on a decedent. Existing law requires a coroner or medical examiner who evaluates an individual who died, in the coroner’s or medical examiner’s expert opinion, as the result of an overdose as a contributing factor, to report the incident to the Overdose Detection Mapping Application Program, as specified.
This bill would authorize a county to establish an interagency overdose fatality review team to assist local agencies in identifying and reviewing overdose fatalities, facilitate communication among the various persons and agencies involved in overdose fatalities, and integrate local overdose prevention efforts through strategic planning, data dissemination, and community collaboration. The bill would authorize the overdose fatality review team to be comprised of, among other persons, experts in the field of forensic pathology, coroners and medical examiners, county, local, state, and federal law enforcement, and public health staff, as specified. The bill would make confidential, among other things, an oral or written communication or a document shared within or produced by an overdose fatality review team related to an overdose fatality review, as specified. The bill would authorize an organization represented on an overdose fatality review team to share information in its possession concerning the decedent who is the subject of the review, information received from a person who was in contact with the decedent, or other information deemed by the organization to be pertinent to the review with other members of the team. The bill would require information gathered and recommendations made by an overdose fatality review team to be used by the county to develop education, prevention, and intervention strategies that will lead to improved coordination of treatment services and prevent future overdose deaths.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 Division 10.1 (commencing with Section 11675) is added to the Health and Safety Code, to read:

DIVISION 10.1. OVERDOSE FATALITY REVIEW TEAMS

11675.
 (a) A county may establish an interagency overdose fatality review team to assist local agencies in identifying and reviewing overdose fatalities, facilitate communication among the various persons and agencies involved in overdose fatalities, and integrate local overdose prevention efforts through strategic planning, data dissemination, and community collaboration.
(b) A county may develop standardized protocols for postmortem examinations involving an overdose to assist coroners and other persons who perform postmortem examinations in determining whether drugs contributed to a death or were the actual cause of death. The protocols may establish written reporting procedures, including the proper designation of the cause and mode of death.

11676.
 An overdose fatality review team may be comprised of, but not limited to, all of the following:
(a) Experts in the field of forensic pathology.
(b) Medical personnel with expertise in overdose fatalities.
(c) Coroners and medical examiners.
(d) District attorneys and city attorneys.
(e) County or local staff, including, but not limited to, all of the following:
(1) Behavioral health services staff.
(2) County counsel.
(3) Emergency medical services staff.
(4) Unhoused services staff.
(5) Medical care services staff.
(6) Medical examiner staff.
(7) Public health staff.
(f) County, local, state, and federal law enforcement personnel.
(g) Local drug trafficking experts.
(h) Public health or behavioral health experts.
(i) Drug treatment providers.
(j) Representatives of local health plans, nonprofits, religious, or other organizations who work with individuals at high risk of overdose fatalities.
(k) Local professional associations of persons described in this subdivision.

11677.
 (a) An oral or written communication or a document shared within or produced by an overdose fatality review team related to an overdose fatality review is confidential and not subject to disclosure or discovery by a third party.
(b) An oral or written communication or a document provided by a third party to an overdose fatality review team, or between a third party and an overdose fatality review team, is confidential and not subject to disclosure or discovery by a third party.
(c) Notwithstanding subdivisions (a) and (b), recommendations of an overdose fatality review team, upon the completion of a review, may be disclosed at the discretion of a majority of the members of the overdose fatality review team.

11678.
 An organization represented on an overdose fatality review team may share information in its possession concerning the decedent who is the subject of the review, information received from a person who was in contact with the decedent, or other information deemed by the organization to be pertinent to the review with other members of the team. Information shared by an organization with other members of a team is confidential.

11679.

(a)(1)Written and oral information may be disclosed to an overdose fatality review team established pursuant to this division. The team may make a request in writing for the information sought and a person with information of the kind described in paragraph (3) may rely on the request in determining whether information may be disclosed to the team.

(2)An individual or agency that has information governed by this division is not required to disclose that information.

(3)The following information may be disclosed pursuant to this division:

(A)Notwithstanding Section 56.10 of the Civil Code, medical information.

(B)Notwithstanding Section 5328 of the Welfare and Institutions Code, mental health information.

11679.
 (a) Consistent with paragraph (9) of subdivision (b) of Section 56.10 of the Civil Code, a provider of health care, as defined in Section 56.05 of the Civil Code, or a covered entity, as defined in Section 160.103 of Title 45 of the Code of Federal Regulations, shall provide to the members of the county overdose fatality review team any information, including protected health information, and mental health records excluding psychotherapy notes, in its possession that is directly related to the review authorized under Section 11675 about the individual involved in the case. The provision of information under this subdivision is a disclosure required by law, which may be made only to the extent permitted under subdivision (a) of Section 164.512 of Title 45 of the Code of Federal Regulations. The information disclosed shall include substance use disorder patient records only to the extent permitted by Part 2 (commencing with Section 2.1) of Title 42 of the Code of Federal Regulations.
(b) The following additional information, only to the extent required for carrying out the reviews authorized by this division, may be disclosed:

(C)

(1) State summary criminal history information, as defined in Section 11105 of the Penal Code, criminal offender record information, as defined in Section 11075 of the Penal Code, and local summary criminal history information, as defined in Section 13300 of the Penal Code.

(D)

(2) Information provided to probation officers in the course of the performance of their duties, including, but not limited to, the duty to prepare reports pursuant to Section 1203.10 of the Penal Code, as well as the information on which these reports are based.

(E)Notwithstanding Section 12300 of the Welfare and Institutions Code, records relating to in-home supportive services, unless disclosure is prohibited by federal law.

(b)Written and oral information may be disclosed under this section notwithstanding Sections 2263, 2918, 4982, and 6068 of the Business and Professions Code, the lawyer-client privilege protected by Article 3 (commencing with Section 950) of Chapter 4 of Division 8 of the Evidence Code, the physician-patient privilege protected by Article 6 (commencing with Section 990) of Chapter 4 of Division 8 of the Evidence Code, and the psychotherapist-patient privilege protected by Article 7 (commencing with Section 1010) of Chapter 4 of Division 8 of the Evidence Code.

11680.
 Information gathered, and recommendations made, by an overdose fatality review team shall be used by the county to develop education, prevention, and intervention strategies that will lead to improved coordination of treatment services and prevent future overdose deaths.

SEC. 2.

 The Legislature finds and declares that Section 1 of this act, which adds Division 10.1 (commencing with Section 11675) to the Health and Safety Code, imposes a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
In order to protect the privacy of persons who have died due to a drug fatality, including confidential medical information, and to encourage the provision of comprehensive information about drug fatalities to the review teams, it is necessary to limit general access to information regarding those persons.
feedback